Preliminary report of an enoxaparin dose protocol based on anti-Xa activity in continuous renal replacement therapy

被引：0
|
作者：
JLF Costa
J Ferreira
C Teles
F Gutierrez
A Mesquita
RC Costa-Filho
机构：
[1] Hospital Pró-Cardíaco,
来源：
Critical Care | / 11卷 / Suppl 3期
关键词：
Enoxaparin; Unfractionated Heparin; Continuous Renal Replacement Therapy; Gastric Lesion; Filter Performance;
D O I：
10.1186/cc5843
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Current enoxaparin dosing strategies yield supratherapeutic anti-Xa activity in many elderly patients
    Leri, F
    Voyce, SJ
    Scialla, S
    Glavich, W
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 509A - 509A
  • [32] A SIMPLE TEST FOR MONITORING PLASMA ANTI-XA ACTIVITY IN PATIENTS AFTER SUBCUTANEOUS ADMINISTRATION OF ENOXAPARIN
    HALBMAYER, WM
    FEICHTINGER, C
    SCHWARZ, T
    GSCHNAIT, F
    STRASSER, A
    PRIESCHING, A
    FISCHER, M
    [J]. WIENER KLINISCHE WOCHENSCHRIFT, 1990, 102 (14) : 408 - 413
  • [33] Lack Of Anti-Xa Assay Standardization Results In Significant Dose Variation In Neonates and Children Receiving Enoxaparin
    Greene, Lindsey A.
    Law, Connie
    Jung, Mike
    Walton, Sara
    Raffini, Leslie J.
    [J]. BLOOD, 2013, 122 (21)
  • [34] Dose in continuous renal replacement therapy
    Claure-Del Granado, Rolando
    [J]. GACETA MEDICA DE MEXICO, 2018, 154 : S40 - S47
  • [35] Achievement of goal anti-Xa activity with weight-based enoxaparin dosing for venous thromboembolism prophylaxis in trauma patients
    Taylor, Ashley
    Huang, Ellen
    Waller, Jennifer
    White, Cassandra
    Martinez-Quinones, Patricia
    Robinson, Tim
    [J]. PHARMACOTHERAPY, 2021, 41 (06): : 508 - 514
  • [36] Anti-Xa activity relates to survival and efficacy in unselected acute coronary syndrome patients treated with enoxaparin
    Montalescot, G
    Collet, JP
    Tanguy, ML
    Ankri, A
    Payot, L
    Dumaine, R
    Choussat, R
    Beygui, F
    Gallois, V
    Thomas, D
    [J]. CIRCULATION, 2004, 110 (04) : 392 - 398
  • [37] Anti-Xa guided enoxaparin dose adjustment improves pharmacologic deep venous thrombosis prophylaxis in burn patients
    Cronin, Brendan J.
    Godat, Laura N.
    Berndtson, Allison E.
    Pham, Arielle
    Kolan, Shobha
    Box, Kevin
    Lee, Jeanne G.
    Costantini, Todd W.
    [J]. BURNS, 2019, 45 (04) : 818 - 824
  • [38] Fixed-Dose Enoxaparin After Bariatric Surgery: The Influence of Body Weight on Peak Anti-Xa Levels
    Celik, Funda
    Huitema, Alwin D. R.
    Hooijberg, Jan H.
    van de Laar, Arnold W. J. M.
    Brandjes, Dees P. M.
    Gerdes, Victor E. A.
    [J]. OBESITY SURGERY, 2015, 25 (04) : 628 - 634
  • [39] Fixed-Dose Enoxaparin After Bariatric Surgery: The Influence of Body Weight on Peak Anti-Xa Levels
    Funda Celik
    Alwin D. R. Huitema
    Jan H. Hooijberg
    Arnold W. J. M. van de Laar
    Dees P. M. Brandjes
    Victor E. A. Gerdes
    [J]. Obesity Surgery, 2015, 25 : 628 - 634
  • [40] Monitoring for anti-Xa activity for prophylactic administration of Fondaparinux in patients with artificial joint replacement
    Kakunoshin Yoshida
    Hideo Wada
    Masahiro Hasegawa
    Hiroki Wakabayashi
    Honami Ando
    Seika Oshima
    Takeshi Matsumoto
    Yuji Shimokariya
    Katsura Noma
    Norikazu Yamada
    Atsumasa Uchida
    Tsutomu Nobori
    Akihiro Sudo
    [J]. International Journal of Hematology, 2011, 94 : 355 - 360
12345